J&J Applies for Covid-19 Vaccine Study in Indian Adolescents
3 years, 4 months ago

J&J Applies for Covid-19 Vaccine Study in Indian Adolescents

News 18  

Johnson & Johnson on Friday said it has submitted an application to the Indian drug regulator to conduct a study of its COVID-19 vaccine in adolescents aged 12-17 years. “On August 17, 2021, we submitted an application to the Central Drugs Standard Control Organisation to conduct a study of the Johnson & Johnson COVID-19 vaccine in India in adolescents aged 12-17 years,” a J&J India spokesperson said in a statement. “We remain deeply committed to the critical work needed to make our COVID-19 vaccine equitably accessible for all age groups,” the company spokesperson noted. Earlier this month, the government had given Emergency Use approval to J&J’s single-dose COVID-19 vaccine in India.

India Vaccine  jj  noted  submitted  study  covid19  johnson  indian  spokesperson  adolescents  applies  approval  vaccine  india

History of this topic

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration
3 months, 3 weeks ago

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration

ABC  

Australia's national drug regulator is evaluating the safety and efficacy of two new COVID-19 vaccines designed to provide better protection against new variants of the virus. While there is no longer much circulation of the original JN.1 variant in Australia, Professor Esterman said the new vaccines — targeting JN.1 — would likely still prove highly effective. While TGA approval isn't …

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
6 months, 2 weeks ago

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines

Associated Press  

WASHINGTON — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called JN.1. But just a few months later, numerous offshoots of JN.1 already are on the rise, prompting Moderna and Pfizer to also test a slightly different vaccine formula targeting …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
7 months, 3 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

Covid variant JN.1 spreading fast; preventive tips for children
11 months, 3 weeks ago

Covid variant JN.1 spreading fast; preventive tips for children

Hindustan Times  

Amid the rapid spread of Covid-19 variant JN.1 globally, over 150 cases of the new strain have been detected in India across several cities. While it's not clear whether the existing vaccinations will provide full protection from this new sub-variant, vulnerable populations including children must follow preventive measures to prevent spread. As the world grapples with the emergence of the …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
11 months, 4 weeks ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

New COVID variant JN.1: Health Ministry says no need for booster dose
1 year ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

Covid in India Highlights: Maharashtra reports nine JN.1 infections
1 year ago

Covid in India Highlights: Maharashtra reports nine JN.1 infections

Hindustan Times  

Covid in India Highlights: India logged a total of 656 fresh cases of Covid-19 infections on December 24. Former AIIMS, Delhi, director Randeep Guleria said the sub-variant JN.1 is “gradually becoming dominant” but observed that it is not causing severe infections or hospitalisations. The World Health Organisation also classified JN.1 into the Variant of Interest category, however, said there is …

Covid-19 cases rise in India: Existing vaccines protect against new JN.1 sub-variant? What expert says
1 year ago

Covid-19 cases rise in India: Existing vaccines protect against new JN.1 sub-variant? What expert says

Live Mint  

Covid 19 cases have started increasing once again in India. JN.1 has extensive resistance across receptor binding domain classes 1, 2, and 3 and shows higher immune evasion as compared with BA 2.86 and other resistant strains. In an interaction with Livemint, Dr. Gurmeet Singh Chabbra, Director-Pulmonary, Marengo Asia Hospitals Faridabad said that according to CDC, vaccines will not block …

Government issues COVID-19 alert, says no clustering of JN.1 cases
1 year ago

Government issues COVID-19 alert, says no clustering of JN.1 cases

The Hindu  

Admitting that India has registered a rise in the daily COVID-19 positivity rate in some States, including Kerala, Maharashtra, Jharkhand and Karnataka, the Union Health Ministry on Wednesday, while issuing an alert, said that no clustering of cases had been reported in the new JN.1 variant of the SARS-CoV-2 coronavirus. The cases that are hospitalised are due to other medical …

WHO classifies JN.1 as 'variant of interest' amid sharp uptick in Covid-19 cases
1 year ago

WHO classifies JN.1 as 'variant of interest' amid sharp uptick in Covid-19 cases

Live Mint  

Amid an uptick in Covid-19 cases across the globe, the World Health Organisation has decided to classify the JN.1 Covid variant as the "variant of interest." The world health body, however, clarified that the JN.1 variant of the Covid-19 virus does not pose much threat to public health. {{^adFree}} {{/adFree}} In India, the JN.1 variant of Covid-19 has alerted the …

COVID-19 sub-strain JN.1 detected in elderly woman from Kerala
1 year ago

COVID-19 sub-strain JN.1 detected in elderly woman from Kerala

The Hindu  

A case of COVID-19 sub-variant JN.1 was detected from the sample of a 79-year-old woman in Kerala on December 8, official sources said on December 16. The senior citizen’s sample had returned a positive result in an RT-PCR test taken on November 18, they said, adding that she had mild symptoms of influenza-like illnesses and had recovered from COVID-19. Previous …

Covid subvariant JN.1 case detected in Kerala, authorities keep a vigil
1 year ago

Covid subvariant JN.1 case detected in Kerala, authorities keep a vigil

India TV News  

A new Covid subvariiant JN.1 case has been reported in Kerala, raising health authorities' concerns. In Kerala, there are reports of people getting Covid, but the severity so far appears to be the same as before," said Rajeev Jayadev, National Indian Medical Association Covid Task Force's co-chairman. India sees over 300 cases on Saturday India recorded a single-day rise of …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 5 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity
1 year, 6 months ago

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity

The Hindu  

With the COVID-19 pandemic exposing the acute inequity in vaccine development and access, the Indian government is working in partnership with two leading global non-profits to convene and build consensus among the G-20 member States and others, for a proposed Global Vaccine Research Collaborative. “International cooperation is essential to advance vaccine development for emerging pathogens, and the G-20 can serve …

Can a new vaccine rollout change this beaten down pharma MNC's fortune in 2023?
1 year, 7 months ago

Can a new vaccine rollout change this beaten down pharma MNC's fortune in 2023?

Live Mint  

It's tough being a pharma company these days.the pharma sector, which once used to be the star of the street, has been witnessing bad times since 2022. Over the last few years, the company has underperformed relative to its peers due to a series of challenges, including oncology clinical failures and missing out on the lucrative market for the first …

India is 1 of 3 countries where confidence in children’s vaccines has increased: UNICEF report
1 year, 8 months ago

India is 1 of 3 countries where confidence in children’s vaccines has increased: UNICEF report

The Hindu  

Only China, India, and Mexico, that is three out of the 55 countries studied for popular perception of the importance of vaccines for children, showed improvement as per data collected by The Vaccine Confidence Project and published by UNICEF on April 20. UNICEF India today released the agency’s global flagship report ‘The State of the World’s Children 2023: For Every …

India among countries with highest vaccine confidence. What about its neighbours
1 year, 8 months ago

India among countries with highest vaccine confidence. What about its neighbours

Hindustan Times  

UNICEF India on Thursday released the agency's global flagship report "The State of the World's Children 2023: For Every Child, Vaccination," highlighting the significance of childhood immunisation. According to Cynthia McCaffrey, UNICEF India Representative, World's Children 2023 report highlights India as one of the countries with the highest vaccine confidence in the world, "The State of the World's Children 2023 …

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine
1 year, 10 months ago

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine

Hindustan Times  

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday. The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's approval in November for restricted emergency use among adults as a heterologous booster dose. According to a statement issued …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

COVID-19 vaccine: How well does India’s adverse reaction tracking system work? | In Focus podcast
2 years ago

COVID-19 vaccine: How well does India’s adverse reaction tracking system work? | In Focus podcast

The Hindu  

Last month, the Central government, in an affidavit to the Supreme Court, said that it cannot be held liable to pay compensation for deaths caused by adverse reactions to the COVID-19 vaccine. The affidavit was filed in a case in response to a petition filed by the parents of two young women, who allegedly died due to adverse reactions following …

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health
2 years, 1 month ago

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health

News 18  

On April 14, 2020, India’s Prime Minister made an appeal to scientists and researchers to take the lead in developing a vaccine against the coronavirus. The group was tasked with formulating an implementation strategy for the Covid-19 vaccine including the selection of vaccine candidates, procurement of vaccines, prioritisation of population groups for vaccination, enabling digital infrastructure, vaccine delivery platforms as …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 2 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 3 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use
2 years, 3 months ago

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use

News 18  

Bharat Biotech has been given an emergency use authorisation by India’s drug regulator, the Drug Controller General of India, for its intranasal Covid-19 vaccine, Union Health Minister Dr Mansukh Mandaviya tweeted on Tuesday. Big Boost to India's Fight Against COVID-19!Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted …

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval
2 years, 3 months ago

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval

India TV News  

The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India for the Intranasal Covid-19 vaccine. Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a 'Big boost' to India's fight against Covid-19. Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for …

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically
2 years, 4 months ago

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically

News 18  

Individuals who have received Covid-19 vaccines abroad and wish to get their second dose or booster shot in India can now do so. The development comes following an August 18 report by the Times of India which highlighted the issues people who had been jabbed abroad faced when they tried to receive a second or third shot here because the …

COVID-19 intranasal vaccine Phase III trials over, proven safe, says Bharat Biotech
2 years, 4 months ago

COVID-19 intranasal vaccine Phase III trials over, proven safe, says Bharat Biotech

Deccan Chronicle  

HYDERABAD: Bharat Biotech International Limited on Monday said its COVID-19 intranasal vaccine has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials phase III. Product development related to pre-clinical safety evaluation, large-scale manufacturing scale-up, formulation, and delivery device development, including human clinical trials, was conducted by Bharat Biotech. Suchitra K Ella, Joint Managing Director, Bharat Biotech, …

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday
2 years, 4 months ago

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday

News 18  

Biological E. Ltd on Thursday said it has delivered 10 crore doses of its Covid-19 vaccine, Corbevax to the Centre so far which is expected to be available as a booster dose on the Cowin App in public and private vaccination centers from Friday. Corbevax was also approved by the Union Health Ministry as a heterologous Covid-19 booster dose under …

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients
2 years, 4 months ago

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients

News 18  

The Centre has approved Biological E’s Corbevax as a Covid-19 precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Union Health Secretary Rajesh Bhushan said, “Corbevax will be available as precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines …

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon
2 years, 4 months ago

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon

News 18  

The Union health ministry is expected to soon approve Biological E’s Corbevax as a precaution dose for people above 18 years who are double vaccinated with either Covishield or Covaxin, official sources said on Tuesday. “Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose …

Adults may get different vaccine as booster shot instead of Covishield, Covaxin
2 years, 4 months ago

Adults may get different vaccine as booster shot instead of Covishield, Covaxin

Live Mint  

As the government has continued to emphasize Covid booster doses due to the rising number of cases, a panel has recommended a different vaccine for Indian adults. Government panel National Technical Advisory Group on Immunisation has recommended Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin. "Corbevax may be considered for a third/precaution …

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre
2 years, 5 months ago

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Centre

Firstpost  

Minister of State for Health Bharati Pravin Pawar said as on 19 July, 2022, a total of 200.34 crore COVID-19 vaccine doses have been administered to beneficiaries above 12 years of age in the country New Delhi: India has supplied 23.9 crore doses of coronavirus vaccine to 101 countries and UN entities in the form of grant, commercial export, or …

’Only 10% got Covid-19 booster dose’: CM Arvind Kejriwal’s appeal to Delhi
2 years, 5 months ago

’Only 10% got Covid-19 booster dose’: CM Arvind Kejriwal’s appeal to Delhi

Live Mint  

Delhi Chief Minister Arvind Kejriwal on Sunday appealed to the people to get their Covid-19 precaution doses while highlighting that only around 10% people have done it so far. A total of 1.81 crore have been given first dose and 1.53 crore have received both doses, the Delhi chief minister said while emphasising that Delhi has capacity to administer one …

India's cumulative Covid-19 vaccination nears 200 crore
2 years, 5 months ago

India's cumulative Covid-19 vaccination nears 200 crore

India Today  

The cumulative Covid-19 vaccine doses administered in the country neared the 200-crore mark on Saturday, the Union health ministry said. Over 14.94 lakh precaution doses of COVID-19 vaccines were given to people in the 18-59 age group till 10 pm, with the majority administered for free under the government's special 75-day drive 'COVID Vaccination Amrit Mahotsav'. The next phase of …

Centre Has Not Got Scientific Advice on Vaccines for Children Aged Below 12: Union Minister
2 years, 5 months ago

Centre Has Not Got Scientific Advice on Vaccines for Children Aged Below 12: Union Minister

News 18  

Union Minister for Health, Chemicals and Fertilisers Mansukh Mandaviya on Thursday said the government has not received any advice from the scientific community on vaccines for children below 12 years of age. About the availability of vaccines, Mandaviya said six companies in the country make vaccines and their manufacturing capacity is around 20 crore doses monthly; they include Corbavax, mRNA …

COVID-19: US FDA authorises Novavax vaccine for emergency use in adults
2 years, 5 months ago

COVID-19: US FDA authorises Novavax vaccine for emergency use in adults

India TV News  

Highlights US regulators OK new COVID-19 shot option from Novavax vaccine Food and Drug Administration on Wednesday cleared Novavax shots for adults in US Novavax makes more traditional type of shot than three other COVID vaccines available for use in US COVID-19 news : The US is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday …

Free Covid booster doses will create healthier country: PM Modi
2 years, 5 months ago

Free Covid booster doses will create healthier country: PM Modi

India Today  

Prime Minister Narendra Modi on Wednesday said the government's decision to administer free precautionary doses of Covid-19 vaccines to all citizens aged above 18 will further India's vaccination coverage and create a healthier country. As part of 'Azadi Ka Amrit Mahotsav' celebrations, free precautionary doses of Covid-19 vaccines will be administered to all citizens above the age of 18 at …

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres
2 years, 5 months ago

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres

The Hindu  

As part of the Azadi Ka Amrit Mahotsav celebrations, free precaution doses of COVID-19 vaccines will be available for all citizens above 18 years of age at government vaccination centres from July 15 for 75 days, Anurag Singh Thakur, Union Minister of Information and Broadcasting, announced on July 13, following a meeting of the Union Cabinet. India’s cumulative COVID-19 vaccination …

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years
2 years, 5 months ago

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years

News 18  

The NTAGI's Standing Technical Sub-Committee approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday. Data of Biological E's Corbevax and Bharat Biotech's Covaxin for children aged between five and 12 years were reviewed in the STSC meeting held on June 16 and members decided that the vaccines …

Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here
2 years, 5 months ago

Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here

Live Mint  

Biological E's Corbevax and Bharat Biotech's Covaxin on July 8 received the nod from the National Technical Advisory Group on Immunisation's Standing Technical Sub-Committee for use among children aged between 5-12 years. The Drugs Controller General of India granted emergency use authorisation to the Biological E's Corbevax for 5-12 year old and Bharat Biotech's Covaxin for minors belonging to the …

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years
2 years, 5 months ago

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years

Live Mint  

The Serum Institute Of India's Covid-19 vaccine Covovax has been approved on Tuesday by the Drugs Controller General of India for children between the age group of 7 and 12 years. The DCGI's nod for restricted emergency use in children came after the subject expert committee on Covid-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax …

Govt Panel Recommends Emergency Approval for SII's Covovax for 7-11 Year Olds
2 years, 6 months ago

Govt Panel Recommends Emergency Approval for SII's Covovax for 7-11 Year Olds

News 18  

An expert panel of India's central drug authority on Friday recommended granting emergency use authorisation to Serum Institute's Covovax for children aged 7 to 11 years, official sources said. "The Subject Expert Committee on Covid-19 of the CDSCO deliberated on the EUA application of SII and recommended granting emergency use authorisation for Covovax for children aged 7 to 11 years," …

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study
2 years, 6 months ago

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study

The Hindu  

COVID-19 vaccines prevented over 42 lakh potential deaths in India in 2021, said a study published in The Lancet Infectious Diseases journal, which based its findings on estimates of "excess" mortalities in the country during the pandemic. In the first year of the vaccination programme, 19.8 million out of a potential 31.4 million COVID-19 deaths were prevented worldwide, according to …

CDC recommends Covid-19 vaccines for children as young as 6 months, clearing the way for vaccinations to begin soon
2 years, 6 months ago

CDC recommends Covid-19 vaccines for children as young as 6 months, clearing the way for vaccinations to begin soon

CNN  

CNN — US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky signed off on Covid-19 vaccinations for children under 5 on Saturday, clearing the way for vaccinations to be administered soon. “Today is a monumental step forward in our nation’s fight against the virus, with virtually every American now eligible for the protections that COVID-19 vaccines provide,” Biden …

FDA authorizes Covid-19 vaccines for younger children
2 years, 6 months ago

FDA authorizes Covid-19 vaccines for younger children

CNN  

CNN — The Moderna and Pfizer/BioNTech Covid-19 vaccines are now authorized for emergency use in young children. “I’m really pleased that we’ve reached this kind of milestone,” said committee member Dr. Ofer Levy, of the Precision Vaccines Program at Boston Children’s Hospital, who also likened the moment to when Covid-19 vaccines previously were authorized for other age groups. “Having vaccine …

FDA moves closer to authorizing COVID-19 shots for kids under 5
2 years, 6 months ago

FDA moves closer to authorizing COVID-19 shots for kids under 5

LA Times  

A 5-year-old received a dose of the Covid-19 vaccine in Los Angeles in May. “This is a long-awaited vaccine,” said one panel member, Dr. Jay Portnoy of Children’s Hospital in Kansas City, Mo. Dr. Peter Marks, the FDA’s vaccine chief, opened the meeting with data showing a “quite troubling surge’’ in young children’s hospitalizations during the Omicron wave, and noted …

FDA advisers vote in favor of authorizing Covid-19 vaccines for children as young as 6 months
2 years, 6 months ago

FDA advisers vote in favor of authorizing Covid-19 vaccines for children as young as 6 months

CNN  

CNN — Vaccine advisers to the US Food and Drug Administration voted unanimously on Wednesday in favor of expanding the emergency use authorizations forthe Moderna and Pfizer/BioNTech Covid-19 vaccines to include children as young as 6 months. All 21 members of the FDA’s Vaccines and Related Biological Products Advisory Committee voted “yes” in response to the question: “Based on the …

Opinion: As the US inches toward Covid vaccines for its youngest, a pediatrician weighs in
2 years, 6 months ago

Opinion: As the US inches toward Covid vaccines for its youngest, a pediatrician weighs in

CNN  

Editor’s Note: Dr. Julie Morita, a pediatrician, is executive vice president of the Robert Wood Johnson Foundation and member of the US Centers for Disease Control and Prevention’s Advisory Committee to the Director. Since vaccines were authorized for children ages 5-11 seven months ago, less than 30% have completed their primary two-dose series, according to data from the US Centers …

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above
2 years, 6 months ago

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above

ABP News  

New Delhi: The Drug Controller General of India approved the Corbevax Covid-19 booster as heterologous Covid-19 booster dose for adults above the age of 18 years who got their primary Covid-19 vaccination of Covishield or Covaxin administered six months before, reported news agency ANI. Recently, BE has furnished its clinical trials data to the DCGI who after a detailed evaluation …

Discover Related